NEW YORK (AP) _ Under immense regulatory and competitive pressure, Schering-Plough Corp. said Friday it planned to switch its blockbuster allergy prescription medicine Claritin to an over-the-counter ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback